A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer
- 8 August 2022
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 127 (8) , 1450-1460
Abstract
Background Gastric cancer (GC) is characterised by a heterogeneous tumour microenvironment (TME) that is closely associated with the response to treatment, especially immunotherapies. However, most previous GC molecular subtyping systems need complex gene signatures and examination methods, restricting their clinical applications. Thus, we developed a new TME-based molecular subtype using only two genes. Methods Nine independent GC cohorts at the tissue- or single-cell level with more than 2000 patients were used in this study, including data we examined by single-cell sequencing, quantitative RT-PCR and immunochemistry/immunofluorescence staining. Nine different methods, five existing molecular subtypes and a series of signatures were used to evaluate the TME and molecular characteristics of GC. Results We established a CTSL/ZBTB7B subtyping system and uncovered the novel CTSLHighZBTB7BLow high-risk subgroup, but characterised by relative higher immune cell infiltration and lower tumour purity. This subgroup demonstrate higher levels of immune checkpoints and more enrichment of cancer-related pathways compared with other cases. Conclusions We identified a high-risk subpopulation with unique TME features based on expressions of CTSL and ZBTB7B, suggesting a counterbalancing phenotype between immunostimulatory and immunosuppressive mechanisms. This subtyping system could be used to select treatment and management strategies for GC.Keywords
This publication has 47 references indexed in Scilit:
- Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expressionGenome Biology, 2016
- Comprehensive analyses of tumor immunity: implications for cancer immunotherapyGenome Biology, 2016
- Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer PatientsAnnals of Surgical Oncology, 2015
- Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric CancerJournal of Histochemistry & Cytochemistry, 2015
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomesNature Medicine, 2015
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Cytokeratins 20 and 7 as biomarkersEuropean Journal of Cancer, 2002
- Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas.1995